Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)

NCT00264147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

761

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: etoricoxib
DRUG: etoricoxib
DRUG: etoricoxib
DRUG: etoricoxib
DRUG: Comparator: placebo
DRUG: etoricoxib
DRUG: Comparator: diclofenac

Sponsor

Organon and Co